title: Marked thrombocytosis after CMF chemotherapy.
authors.forename: U
authors.initials: U
authors.lastname: Bolzern
authors.forename: R
authors.initials: R
authors.lastname: Biasioli
authors.forename: E
authors.initials: E
authors.lastname: Rinaldi
authors.forename: S
authors.initials: S
authors.lastname: Negretti
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D013922:Thrombocytosis / Q000139:chemically induced*
chemical_list: D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate